Transcriptomics

Dataset Information

0

Effect of c-MET inhibitor SU11274 upon sensitive (RPMI8226) or multi-resistant (RPMI8226/R5) Multiple Myeloma cell lines


ABSTRACT: The c-MET signaling axis is increasingly implicated in tumorigenesis and chemioresistance. In this study, we investigated gene expression modifications induced by SU11274 (Selleck Chemicals, Boston, USA), a novel selective c-MET inhibitor, in a pair of isogenic multiple myeloma (MM) cell lines either sensitive (RPMI8226) or multi-resistant, highly c-MET expressing (RPMI8226/R5) cells. On the whole, RPMI8226/R5 cells after SU11274 were characterised by wider and diverse gene expression modifications than RPMI8226, indicating that c-MET over-expression, and its inhibition, is an important aspect of the adaptive response associated to drug resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE38204 | GEO | 2012/05/25

SECONDARY ACCESSION(S): PRJNA167513

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-05-24 | E-GEOD-38204 | biostudies-arrayexpress
| PRJNA350365 | ENA
2013-12-03 | GSE45388 | GEO
2014-10-15 | GSE48909 | GEO
| PRJNA167513 | ENA
2013-12-03 | E-GEOD-45388 | biostudies-arrayexpress
2022-09-06 | GSE202672 | GEO
2014-10-15 | E-GEOD-48909 | biostudies-arrayexpress
2023-12-06 | GSE237216 | GEO
2010-10-25 | E-GEOD-21811 | biostudies-arrayexpress